Literature DB >> 6245884

The enhancement of cytotoxicity of N-methyl-N-nitrosourea and of gamma-radiation by inhibitors of poly(ADP-ribose) polymerase.

N Nduka, C J Skidmore, S Shall.   

Abstract

Inhibitors of poly(ADP-ribose) polymerase show a synergistic potentiation of cytotoxicity with certain DNA-damaging agents. Non-toxic concentrations of 5-methylnicotinamide dramatically potentiate the cytotoxicity of N-methyl-N-nitrosourea as tested by the cloning ability of mouse leukaemia (L1210) cells. A dose-enhancement factor of about 10 is observed. This potentiation is dependent on the concentration of 5-methylnicotinamide. The methylxanthines theobromine, theophylline and caffeine also increase the cytotoxicity of methylnitrosourea. Thymidine, in the presence of sufficient deoxycytidine to overcome the perturbation of deoxynucleotide metabolism, also potentiates the cytotoxicity of methylnitrosourea. Nicotinate, which is not an inhibitor of poly-(ADP-ribose) polymerase, has no effect on methylnitrosourea toxicity. A very small, but consistent, enhancement of the toxicity of gamma-radiation by the same inhibitors has been observed. We suggest that this potentiation of cytotoxicity is mediated by inhibition of (ADP-ribose)n biosynthesis; and that the biosynthesis is stimulated by DNA damage. We therefore propose that (ADP-ribose)n takes part in cellular repair mechanisms, either by modifying chromatin structure or by a specific participation in DNA repair.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6245884     DOI: 10.1111/j.1432-1033.1980.tb04528.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  21 in total

1.  Biological effects in a chemical factory with mutagenic exposure. II. Analysis of unscheduled DNA synthesis and adenosine diphosphate ribosyl transferase, epoxide hydrolase, and glutathione transferase in resting mononuclear leukocytes.

Authors:  R Pero; L Hagmar; J Seidegård; T Bellander; R Attewell; S Skerfving
Journal:  Int Arch Occup Environ Health       Date:  1988       Impact factor: 3.015

2.  Growth-phase-dependent response to DNA damage in poly(ADP-ribose) polymerase deficient cell lines: basis for a new hypothesis describing the role of poly(ADP-ribose) polymerase in DNA replication and repair.

Authors:  S Chatterjee; N A Berger
Journal:  Mol Cell Biochem       Date:  1994-09       Impact factor: 3.396

Review 3.  Introductory review: involvement of ADP-ribosylation in cellular recovery from some forms of DNA damage.

Authors:  J Lunec
Journal:  Br J Cancer Suppl       Date:  1984

4.  Sensitization of C6 glioma to carboplatin cytotoxicity by hyperthermia and thymidine.

Authors:  J D Cohen; H I Robins; M J Javid
Journal:  J Neurooncol       Date:  1990-08       Impact factor: 4.130

5.  The production of antibodies to DNA in normal mice following immunization with poly(ADP-ribose).

Authors:  J T Sibley; R P Braun; J S Lee
Journal:  Clin Exp Immunol       Date:  1986-06       Impact factor: 4.330

6.  The influence of inhibitors of poly (ADP-ribose) polymerase on X-ray-induced potentially lethal damage repair.

Authors:  D M Brown; J W Evans; J M Brown
Journal:  Br J Cancer Suppl       Date:  1984

7.  Post-irradiation sensitization with the ADP-ribosyltransferase inhibitor 3-acetamidobenzamide.

Authors:  J Lunec; A M George; M Hedges; W A Cramp; W J Whish; B Hunt
Journal:  Br J Cancer Suppl       Date:  1984

8.  Inhibitors of poly (ADP-ribose) synthesis enhance radiation response by differentially affecting repair of potentially lethal versus sublethal damage.

Authors:  E Ben-Hur; H Utsumi; M M Elkind
Journal:  Br J Cancer Suppl       Date:  1984

9.  Acute changes in glucose uptake after treatment: the effects of carmustine (BCNU) on human glioblastoma multiforme.

Authors:  J M Rozental; J D Cohen; M P Mehta; R L Levine; J M Hanson; R J Nickles
Journal:  J Neurooncol       Date:  1993-01       Impact factor: 4.130

10.  Oxidant injury of cells. DNA strand-breaks activate polyadenosine diphosphate-ribose polymerase and lead to depletion of nicotinamide adenine dinucleotide.

Authors:  I U Schraufstatter; D B Hinshaw; P A Hyslop; R G Spragg; C G Cochrane
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.